PMID- 21290392 OWN - NLM STAT- MEDLINE DCOM- 20110714 LR - 20220331 IS - 1096-9101 (Electronic) IS - 0196-8092 (Linking) VI - 43 IP - 3 DP - 2011 Mar TI - Phototherapy for chronic rhinosinusitis. PG - 187-91 LID - 10.1002/lsm.21042 [doi] AB - OBJECTIVES: Near-infrared laser illumination (NILI), with or without photo-activated (PA) agents, has bactericidal and wound healing promoting effects. NILI may have a potential role managing chronic rhinosinusitis (CRS). METHODS: A prospective randomized study with 23 symptomatic post-surgical CRS patients with positive cultures was conducted. Two groups (GR1 and GR2) were treated with NILI. Objective nasal endoscopic scoring (NES) was elaborated. GR1 was treated with a 940 nm laser, while GR2 was treated with a topical PA agent, indocyanine-green, followed with 810 nm laser. SNOT20 scores, NES, and cultures were obtained prior to illumination. Saccharin test was performed 1 week following treatment. RESULTS: Some cultures remained positive through treatment, with Staph. aureus predominating. Both therapy arms demonstrated clinical efficacy. The SNOT20 score change was 0.9, 0.8 for GR1 and GR2, respectively (P < 0.05). Improvement (P < 0.05) was observed based on NES. No significant difference was observed between two treatment groups. All passed the saccharin test. Therapeutic effect was sustained for a minimum of 2 months. Side effects were minimal. CONCLUSIONS: NILI was objectively and subjectively beneficial in managing CRS, safe, reproducible, sustained and appeared not to interfere with ciliary motility. CRS exacerbation was avoided without using antibiotics or steroids. CI - Copyright (c) 2011 Wiley-Liss, Inc. FAU - Krespi, Yosef P AU - Krespi YP AD - St. Luke's-Roosevelt Hospital, New York, NewYork, USA. krespi@nyhni.org FAU - Kizhner, Victor AU - Kizhner V LA - eng PT - Journal Article PT - Randomized Controlled Trial DEP - 20110202 PL - United States TA - Lasers Surg Med JT - Lasers in surgery and medicine JID - 8007168 RN - 0 (Photosensitizing Agents) RN - IX6J1063HV (Indocyanine Green) SB - IM MH - Chronic Disease MH - Endoscopy MH - Female MH - Humans MH - Indocyanine Green/*therapeutic use MH - Lasers, Semiconductor/*therapeutic use MH - *Low-Level Light Therapy MH - Male MH - Middle Aged MH - *Photochemotherapy MH - Photosensitizing Agents/*therapeutic use MH - Prospective Studies MH - Quality of Life MH - Rhinitis/*drug therapy/microbiology/*radiotherapy MH - Severity of Illness Index MH - Sinusitis/*drug therapy/microbiology/*radiotherapy MH - Treatment Outcome EDAT- 2011/02/04 06:00 MHDA- 2011/07/16 06:00 CRDT- 2011/02/04 06:00 PHST- 2010/12/22 00:00 [accepted] PHST- 2011/02/04 06:00 [entrez] PHST- 2011/02/04 06:00 [pubmed] PHST- 2011/07/16 06:00 [medline] AID - 10.1002/lsm.21042 [doi] PST - ppublish SO - Lasers Surg Med. 2011 Mar;43(3):187-91. doi: 10.1002/lsm.21042. Epub 2011 Feb 2.